Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once touted as a future blockbuster – after it failed the Phase 3 CMVictory trial ...

Please provide your email address to receive an email when new articles are posted on . NEW YORK — Congenital cytomegalovirus is the most common nongenetic cause of hearing loss in childhood, yet many ...

Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a ...

Oct 22 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it would stop developing its experimental vaccine to prevent cytomegalovirus, a virus that can cause birth defects, after it failed ...

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.

Cytomegalovirus (CMV) recently caused a 2-month-old girl in Pennsylvania to suffer severe hearing loss after it was passed to her in the womb. While the virus can exist in a person for life without ...

June is Cytomegalovirus (CMV) Awareness Month, and many parents have never even heard of it. According to the Centers for Disease Control and Prevention, CMV is the leading infectious cause of birth ...

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in Nature Microbiology, reveals an opportunity for developing a therapy against ...

The CMV-22 Osprey is designed to give carrier strike groups and distributed fleets a critical advantage in the unpredictable, dispersed battlespaces of today and tomorrow: agility and flexibility. The ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Cytomegalovirus (CMV) Infection pipeline constitutes 15+ key companies continuously working towards developing 20+ ...